Microbio (4128) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 中天

Microbio (4128) reported revenue of NT$169.6 million for Oct 2026, -3.1% year on year and +12.7% from the previous month. Revenue for Jan–Oct 2026 was NT$1.61 billion (+3.1% year on year).

In Oct 2026, it ranked No. 48 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$161.2 million24/10Nov 2024 NT$158.4 millionDec 2024 NT$155.3 millionJan 2025 NT$165.6 millionFeb 2025 NT$133.4 million25/02Mar 2025 NT$157.5 millionApr 2025 NT$157.1 millionMay 2025 NT$152 millionJun 2025 NT$144.1 million25/06Jul 2025 NT$156.5 millionAug 2025 NT$156.5 millionSep 2025 NT$160.8 millionOct 2025 NT$175 million25/10Nov 2025 NT$171.2 millionDec 2025 NT$164.4 millionJan 2026 NT$180 millionFeb 2026 NT$152 million26/02Mar 2026 NT$169.6 millionApr 2026 NT$159.9 millionMay 2026 NT$158.3 millionJun 2026 NT$161.1 million26/06Jul 2026 NT$152 millionAug 2026 NT$154.5 millionSep 2026 NT$150.4 millionOct 2026 NT$169.6 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$169.6 million-3.1%+12.7%
Sep 2026NT$150.4 million-6.5%-2.6%
Aug 2026NT$154.5 million-1.3%+1.6%
Jul 2026NT$152 million-2.8%-5.6%
Jun 2026NT$161.1 million+11.9%+1.8%
May 2026NT$158.3 million+4.1%-1.0%
Apr 2026NT$159.9 million+1.8%-5.8%
Mar 2026NT$169.6 million+7.7%+11.6%
Feb 2026NT$152 million+14.0%-15.6%
Jan 2026NT$180 million+8.7%+9.5%
Dec 2025NT$164.4 million+5.9%-4.0%
Nov 2025NT$171.2 million+8.1%-2.2%
Oct 2025NT$175 million+8.6%+8.8%
Sep 2025NT$160.8 million+10.2%+2.7%
Aug 2025NT$156.5 million+8.7%+0.0%
Jul 2025NT$156.5 million+13.0%+8.6%
Jun 2025NT$144.1 million+14.4%-5.2%
May 2025NT$152 million+10.4%-3.2%
Apr 2025NT$157.1 million+9.4%-0.2%
Mar 2025NT$157.5 million+8.3%+18.1%
Feb 2025NT$133.4 million+5.9%-19.5%
Jan 2025NT$165.6 million+17.3%+6.7%
Dec 2024NT$155.3 million+12.8%-1.9%
Nov 2024NT$158.4 million+9.1%-1.7%
Oct 2024NT$161.2 million+6.7%+10.4%

Jan–Oct 2026 cumulative: NT$1.61 billion (+3.1% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Microbio vs PEC / Microbio vs Lotus Pharm / Microbio vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16